News

Suvoda anuncia la disponibilidad general de una nueva y potente solución de eCOA

by

Suvoda cubre las lagunas de las soluciones eCOA tradicionales, agilizando y simplificando la concesión de licencias para cuestionarios, la localización y el diseño para una implantación más rápida FILADELFIA, 23 de mayo de 2023 /PRNewswire/ — Suvoda LLC, compañía global de tecnología para ensayos clínicos especializada en estudios complejos en áreas terapéuticas como oncología, sistema nervioso … Read more

MolecuLight® condujo a cambios en el plan de tratamiento de heridas en hasta el 53% de los casos

by

– El mayor estudio publicado sobre imágenes de heridas en el mundo real indica que MolecuLight® condujo a cambios en el plan de tratamiento de heridas en hasta el 53% de los casos Los resultados de 211 centros muestran que MolecuLight Imaging es una herramienta valiosa para mejorar el tratamiento de las infecciones bacterianas Fluorescence-informed … Read more

Results for the first quarter 2023

by

OSLO, Norway, May 23, 2023 /PRNewswire/ — Highlights in the quarter             Continued production ramp up at Indre Harøy. Batch 5 stocked in February and all-time high biomass production in March. Focus on international expansion plans, both in South Korea and North America.            Indre Harøy phase 2 preparations ongoing – … Read more

CORVIA MEDICAL VERÖFFENTLICHT DIE ERGEBNISSE DER ZWEI JAHRE DAUERNDEN CLINICAL TRIAL, DIE DEN NUTZEN UND DIE SICHERHEIT DES ATRIALEN SHUNTS BEI PATIENTEN MIT HERZVERSAGEN BESTÄTIGEN USA – Deutsch USA – español

by

ERSTE RANDOMISIERTE, KONTROLLIERTE PHASE-III-STUDIE ZUR VORHOF-SHUNT-THERAPIE ZEIGT WEITERHIN VIELVERSPRECHENDE ERGEBNISSE  TEWKSBURY, Massachusetts, 23. Mai 2023 /PRNewswire/ — Corvia Medical, Inc., ein Unternehmen, das die Behandlung der Herzinsuffizienz revolutionieren will, gab heute die Zweijahresergebnisse der randomisierten klinischen Studie REDUCE LAP-HF II bekannt, die die Sicherheit und nachhaltige Wirksamkeit des Corvia® Atrial Shunt bei entsprechend ausgewählten Herzinsuffizienzpatienten mit … Read more

Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health’s ModeX Therapeutics

by

CAMBRIDGE, Mass., May 23, 2023 /PRNewswire/ — Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from “Idea to IND” (I to ITM), today announced it has entered into an agreement with ModeX Therapeutics, an OPKO Health company, for the use of Nona’s platforms … Read more

Biomaterials Market size to grow by USD 12,907.35 million from 2022 to 2027, The rising demand for medical implants to drive the market growth

by

NEW YORK, May 23, 2023 /PRNewswire/ — The biomaterials market size is set to grow by USD 12,907.35 million from 2022 to 2027, progressing at a CAGR of 6% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The rising demand for … Read more

Blood Viscometer Market size to grow by USD 13,049.76 thousand from 2022 to 2027; Growth driven by increasing incidence of vascular diseases- Technavio

by

NEW YORK, May 22, 2023 /PRNewswire/ –The blood viscometer market size is set to grow by USD 13,049.76 thousand from 2023 to 2027 progressing at a CAGR of 7.22% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven … Read more

Development of Plasma Derived Therapies Drives Growth

by

DUBLIN, May 22, 2023 /PRNewswire/ — The “Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to  ResearchAndMarkets.com’s offering. The global protein therapeutics market is expected to grow at a CAGR of around 5.9% during 2023-2030. Companies Mentioned  Abbott Laboratories Amgen, Inc. AstraZeneca PLC Baxter International, Inc. Biogen, Inc. … Read more

Rakuten Medical to Start a Global Phase 3 Trial of Alluminox™ Treatment using ASP-1929 for Recurrent Head and Neck Cancer in India

by

SAN DIEGO, May 22, 2023 /PRNewswire/ — Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™ platform, today announced that the Company has been granted permission from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global, pivotal Phase 3 clinical trial (ASP-1929-301/ClinicalTrials.gov … Read more

Increasing Spending on Cultural and Sports Tourism Bolsters Growth

by

DUBLIN, May 22, 2023 /PRNewswire/ — The “Wellness Tourism Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global wellness tourism market grew from $821.75 billion in 2022 to $819.9 billion in 2023 at … Read more